Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Halabi

Showing results (31-40 of 282) with videos related to

Pageof 29
Sort By:
Statistics in Medicine|March 16, 2021
On the design and the analysis of stratified biomarker trials in the presence of measurement errorSusan Halabi, Chen-Yen Lin, Aiyi Liu
Journal of Applied Statistics|June 20, 2025
Sample Size Selection in Clinical Trials when Population Means Are Subject to a Partial Order: One-sided Ordered AlternativesBahadur Singh, Susan Halabi, Michael J Schell
Journal of Biopharmaceutical Statistics|May 6, 2003
Analysis of survival data with missing measurements of a time-dependent binary covariateSusan Halabi, Chuan-Chuan Wun, Barry R Davis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2012
Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycinAndrew J Armstrong, Daniel J George, Susan Halabi
JAMA Oncology|June 16, 2022
To Treat or Not to Treat Men With Low-risk or Intermediate-risk Prostate Cancer-Weighing the EvidenceSusan Halabi, Bradley C Carthon, Wm Kevin Kelly
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Reply to F. Valcamonico et alMatthew R Smith, Susan Halabi, Eric J Small
Pharmaceutical Statistics|August 11, 2020
Score and deviance residuals based on the full likelihood approach in survival analysisSusan Halabi, Sandipan Dutta, Yuan Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2013
Reply to M A Khattak et alAndrew J Armstrong, Daniel J George, Susan Halabi
Bioengineering (Basel, Switzerland)|November 27, 2025
A Two-Step Variable Selection Strategy for Multiply Imputed Survival Data Using Penalized Cox ModelsQian Yang, Bin Luo, Chenxi Yu, et al.
Communications in Statistics: Theory and Methods|May 21, 2026
Residual-Based Sieve Maximum Full Likelihood Estimation for the Proportional Hazards ModelTaehwa Choi, Susan Halabi, Hyotae Kim, et al.
Pageof 29

Showing results (31-40 of 282) with videos related to

Sort By:
Pageof 29
Statistics in Medicine|March 16, 2021
On the design and the analysis of stratified biomarker trials in the presence of measurement errorSusan Halabi, Chen-Yen Lin, Aiyi Liu
Journal of Applied Statistics|June 20, 2025
Sample Size Selection in Clinical Trials when Population Means Are Subject to a Partial Order: One-sided Ordered AlternativesBahadur Singh, Susan Halabi, Michael J Schell
Journal of Biopharmaceutical Statistics|May 6, 2003
Analysis of survival data with missing measurements of a time-dependent binary covariateSusan Halabi, Chuan-Chuan Wun, Barry R Davis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2012
Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycinAndrew J Armstrong, Daniel J George, Susan Halabi
JAMA Oncology|June 16, 2022
To Treat or Not to Treat Men With Low-risk or Intermediate-risk Prostate Cancer-Weighing the EvidenceSusan Halabi, Bradley C Carthon, Wm Kevin Kelly
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Reply to F. Valcamonico et alMatthew R Smith, Susan Halabi, Eric J Small
Pharmaceutical Statistics|August 11, 2020
Score and deviance residuals based on the full likelihood approach in survival analysisSusan Halabi, Sandipan Dutta, Yuan Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2013
Reply to M A Khattak et alAndrew J Armstrong, Daniel J George, Susan Halabi
Bioengineering (Basel, Switzerland)|November 27, 2025
A Two-Step Variable Selection Strategy for Multiply Imputed Survival Data Using Penalized Cox ModelsQian Yang, Bin Luo, Chenxi Yu, et al.
Communications in Statistics: Theory and Methods|May 21, 2026
Residual-Based Sieve Maximum Full Likelihood Estimation for the Proportional Hazards ModelTaehwa Choi, Susan Halabi, Hyotae Kim, et al.
Pageof 29